| View |
|
DR-XY44082
|
Zoledronic Acid
|
Zinvel
|
4 mg / 5 mL
|
Concentrate Solution For Iv Infusion
|
-
|
Gland Pharma Limited
|
India
|
-
|
14 February 2020
|
28 January 2025
|
| View |
|
DR-XY44083
|
Potassium Citrate (as monohydrate)
|
Noston
|
1.08 g (10 mEq)
|
Extended- Release Tablet
|
-
|
Eskayef Pharmaceuticals Limited
|
Bangladesh
|
-
|
12 January 2021
|
22 January 2025
|
| View |
|
DR-XY44089
|
Isotretinoin
|
Acnoin-10
|
10 mg
|
Softgel Capsule
|
-
|
Renown Pharmaceuticals Pvt. Ltd.
|
India
|
-
|
10 June 2020
|
29 January 2025
|
| View |
|
DR-XY44090
|
Meropenem (As Trihydrate)
|
Sitipenam
|
1g
|
Powder For Injection (I.V.)
|
-
|
Intracin Pharmaceuticals Pvt. Ltd.
|
India
|
Initial (from Monitored Release)
|
07 June 2022
|
22 January 2025
|
| View |
|
DR-XY44096
|
Pregabalin
|
None
|
75mg
|
Capsule
|
Anti-epileptic
|
Drugmaker's Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
28 February 2022
|
23 January 2027
|
| View |
|
DR-XY44097
|
Docetaxel (As Trihydrate)
|
Anmotic
|
40 mg/mL
|
Concentrate Solution for IV Infusion
|
Antineoplastic
|
Adley Formulations
|
India
|
Initial
|
21 January 2022
|
23 January 2025
|
| View |
|
DR-XY44098
|
Montelukast (as sodium) + Levocetirizine hydrochloride
|
Co-Altria Ped
|
5 mg/ 2.5 mg
|
Chewable Tablet
|
Leukotriene Receptor Antagonist-Antihistamine
Combination
|
Ajanta Pharma Limited
|
India
|
Monitored Release
|
11 March 2022
|
26 January 2025
|
| View |
|
DR-XY44099
|
Montelukast (as sodium) + Levocetirizine hydrochloride
|
Co-Altria Ped
|
5 mg/5 mg
|
Chewable Tablet
|
Leukotriene Receptor Antagonist-Antihistamine
Combination
|
Ajanta Pharma Limited
|
India
|
Monitored Release
|
11 March 2022
|
26 January 2025
|
| View |
|
DR-XY44102
|
Aspirin + Rosuvastatin (as calcium)
|
Rosuprin
|
80mg/10mg
|
Capsule
|
Lipid Modifying Agents
|
Ajanta Pharma Limited
|
India
|
Initial (from Monitored Release status) Re-issuance
|
24 May 2022
|
26 January 2025
|
| View |
|
DR-XY44103
|
Aspirin + Rosuvastatin (as calcium)
|
Rosuprin
|
80mg/20mg
|
Capsule
|
Lipid Modifying Agent
|
Ajanta Pharma Limited
|
India
|
Initial (from Monitored Release status) Re-issuance
|
10 May 2022
|
26 January 2025
|
| View |
|
DR-XY44104
|
Cefuroxime (As Sodium)
|
Zicef
|
750mg
|
Powder For Injection (IM/IV)
|
-
|
China National (Group) Corporation of Medicines, Guorui Pharmaceutical Co., Ltd.
|
China
|
-
|
29 January 2020
|
26 January 2025
|
| View |
|
DR-XY44105
|
Salbutamol (as sulfate)
|
I-Breath
|
100 mcg
|
Pressurized Metered Dose for Inhalation
|
-
|
The ACME Laboratories Inc.
|
Bangladesh
|
-
|
26 December 2019
|
29 January 2025
|
| View |
DR-XY44106_PIL_01.pdf
|
DR-XY44106
|
Guaifenesin+Phenylephrine+Chlorphenamine Maleate
|
Pleuragex
|
100mg/5mg/2mg per 5 mL
|
Syrup
|
-
|
San Marino Laboratories, Corporation
|
Philippines
|
-
|
15 November 2021
|
26 January 2025
|
| View |
|
DR-XY44107
|
Ademetionine (as butanedisulfonate)
|
Transmetil
|
500 mg
|
Tablet
|
-
|
AbbVie S.r.L.
|
Italy
|
Initial (from Monitored Release status) Re-issuance
|
10 May 2022
|
26 January 2025
|
| View |
|
DR-XY44108
|
Atenolol
|
None
|
50 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
09 January 2020
|
23 January 2025
|
| View |
|
DR-XY44110
|
Atenolol
|
Tenol
|
50 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
29 January 2020
|
23 January 2025
|
| View |
|
DR-XY44113
|
Amitriptyline Hydrochloride
|
Tripmed
|
25 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
17 December 2020
|
23 January 2025
|
| View |
|
DR-XY44114
|
Amitriptyline Hydrochloride
|
None
|
25 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
20 February 2020
|
23 January 2025
|
| View |
|
DR-XY44116
|
Telmisartan
|
None
|
40 mg
|
Tablet
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
19 December 2019
|
23 January 2025
|
| View |
|
DR-XY44120
|
Ceftriaxone (As Sodium)
|
Ceftrirex
|
1 g
|
Powder For Solution For Injection (Im/Iv)
|
-
|
Jiangxi Xier Kangtai Pharmaceutical Co., Ltd.
|
China
|
-
|
08 October 2019
|
28 January 2025
|